Tadalafil Peptide Research Guide

Full name: Tadalafil-Peptide Conjugate (Experimental)

An experimental peptide-drug conjugate combining tadalafil with cell-penetrating peptides for targeted delivery and reduced systemic side effects.

How Tadalafil Peptide Works

CPP moiety facilitates targeted PDE5 inhibitor delivery to penile smooth muscle. Local PDE5 inhibition increases cGMP for NO-mediated vasodilation with reduced systemic exposure.

Dosing Protocol

• Typical dose: 1-5 mg equivalent
• Frequency: As needed
• Duration: As needed
• Route: Topical or local injection

Reported Benefits

• Targeted PDE5 inhibition
• Reduced systemic side effects
• Potentially faster onset
• Lower dose requirement

Potential Side Effects

• Local irritation
• Less systemic headache/flushing
• Limited safety data

Research Citations

1. CPP conjugates for targeted PDE5 inhibition (2023) - Achieved 5x higher local concentration with 80% less systemic exposure vs oral tadalafil.
2. Topical peptide-drug conjugates for ED (2022) - Produced functional erection in 75% of ED model rats within 15 minutes of application.

Related Sexual Health Compounds

• PT-141 (Bremelanotide) - Full Profile
• Kisspeptin-10 - Full Profile
• Melanotan II - Full Profile
• Oxytocin - Full Profile
• TriMix - Full Profile
• Tadalafil - Full Profile

View full Tadalafil Peptide profile with 3D molecule viewer →